Professor Bruce Robinson is an endocrinologist with over 40 years medical and research experience and has published over 300 peer-reviewed scientific articles. During his career, Bruce has been Dean of Medicine at the University of Sydney, Chair of the National Health and Medical Research Council (NHMRC) and Chair of the Medical Benefits Schedule Taskforce in Australia. Over the last 12 years, Bruce has been a non-executive director in a number of ASX-listed healthcare companies including Cochlear Limited, Mayne Pharma Limited and QBiotics Group.
Bruce Robinson
October 28, 2024
CS Pharmaceuticals Ltd (“CSP” or “the Company”), a specialty pharmaceutical company focussed on the in-license of China rights of innovative products and the development and commercialisation of them…